使用基础胰岛素和胰高血糖素样肽-1受体激动剂联合治疗2型糖尿病，以满足未被满足的治疗需求
Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Using Combinations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist.
作者信息
Baron Helen L
机构信息
Director, Bone Mineral Density Unit, Assistant Professor of Clinical Medicine, Division of Endocrinology, Diabetes and Metabolism, Keck Medical Center of USC, Los Angeles, CA, USA.
出版信息
J Fam Pract. 2017 Oct;66(10 Suppl):S17-S28.
PMID:28991933
Abstract
This article presents the rationale and data for combining a basal insulin with a GLP-1RA, including as fixed-ratio products.
摘要
本文介绍了将基础胰岛素与胰高血糖素样肽-1受体激动剂（GLP-1RA）联合使用的基本原理和数据，包括固定比例复方制剂。
Zotero 插件